52.00 0.00 (0.00%)
After hours: 4:32PM EST
|Bid||47.40 x 300|
|Ask||57.00 x 1000|
|Day's range||51.00 - 54.00|
|52-week range||10.55 - 54.00|
|PE ratio (TTM)||N/A|
|Earnings date||12 Mar 2018 - 16 Mar 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||56.17|
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that Tassos Gianakakos, Chief Executive Officer, is scheduled to present at the 36th Annual J.P. Morgan Healthcare Conference on Tuesday, January 9th, 2018, at 2:30 p.m. PT (5:30 p.m. ET) in San Francisco.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 42 cents. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed ...
Jim Cramer rattles off his take on callers' favorite stocks at lightning speed, including one struggling steel producer.
U.S. stocks were slightly higher in afternoon trading on Monday, with the Dow on track to close at a record high for the ninth straight session. While the energy sector was the biggest drag on the S&P 500 due to falling oil prices, this was partly offset by support from consumer stocks such as Wal-Mart Stores.